Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Dynavax Technologies Corporation - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
DVAX
Nasdaq
2834
www.dynavax.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Dynavax Technologies Corporation
Citizens JMP Reiterates a Buy Rating on Dynavax Technologies (DVAX) With a Price Target of $31
- Jul 6th, 2025 2:15 am
Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting
- Jun 11th, 2025 9:01 am
Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom
- Jun 9th, 2025 6:30 am
Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting
- Jun 9th, 2025 5:30 am
Dynavax Comments on Glass Lewis Recommendation
- Jun 4th, 2025 2:59 pm
Glass Lewis backs two of Deep Track's four nominees in Dynavax fight
- Jun 4th, 2025 11:40 am
Glass Lewis Recommends Shareholders Support Deep Track’s Case for Board Change at Dynavax Technologies
- Jun 4th, 2025 7:27 am
Dynavax to Present at William Blair's 45th Annual Growth Stock Conference
- May 28th, 2025 2:10 pm
Deep Track Capital Comments on ISS Recommendation
- May 23rd, 2025 4:12 pm
ISS backs Dynavax directors in board fight with Deep Track Capital
- May 23rd, 2025 11:54 am
Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote "FOR" All Four of Dynavax's Highly Qualified Director Nominees
- May 23rd, 2025 11:35 am
Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting
- May 15th, 2025 2:00 pm
Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value
- May 12th, 2025 5:30 am
/C O R R E C T I O N -- Dynavax Technologies/
- May 9th, 2025 6:38 pm
Dynavax Technologies (DVAX) Upgraded to Buy: Here's Why
- May 8th, 2025 10:00 am
Dynavax Technologies First Quarter 2025 Earnings: EPS Misses Expectations
- May 8th, 2025 5:01 am
Dynavax Technologies Corp (DVAX) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ...
- May 7th, 2025 1:19 am
Dynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue Estimates
- May 6th, 2025 3:15 pm
Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs
- May 6th, 2025 2:01 pm
Deep Track Capital Releases Investor Presentation on Dynavax Technologies
- May 6th, 2025 6:00 am
Scroll